Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation
- 1 June 2012
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 5 (6), 626-635
- https://doi.org/10.1016/j.jcin.2012.02.014
Abstract
No abstract availableKeywords
Funding Information
- Abbott Vascular
This publication has 26 references indexed in Scilit:
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents: 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV TrialJournal of the American College of Cardiology, 2011
- Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting StentsCirculation, 2009
- Observations and Outcomes of Definite and Probable Drug-Eluting Stent Thrombosis Seen at a Single Hospital in a Four-Year PeriodThe American Journal of Cardiology, 2008
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting StentsJournal of the American College of Cardiology, 2008
- Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery DiseaseJama-Journal Of The American Medical Association, 2008
- Off-Label Use of Drug-Eluting Stents: Putting it in PerspectiveJournal of the American College of Cardiology, 2008
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsThe New England Journal of Medicine, 2007
- Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting StentsJournal of the American College of Cardiology, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004